$8.81
At close: May 5 EDT
$8.81
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Gyre Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GYRE | Benzinga
Gyre Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 17
EPS
$0.000
Quarterly Revenue
$27.87M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$105.76M
Analyze the earnings history of Gyre Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE | Gyre Therapeutics | -$1.41 | — | — | — | $113.45M | — | — | — | 05/20/2025 | Get Alert |
| GYRE | Gyre Therapeutics | $0.03 | — | — | — | $27.17M | — | — | — | 05/19/2025 | Get Alert |
| GYRE | Gyre Therapeutics | -$1.39 | — | $0.00 | — | $27.15M | — | $27.87M | — | 03/17/2025 | Get Alert |
| GYRE | Gyre Therapeutics | $0.05 | — | $0.01 | — | $32.04M | — | $25.49M | — | 11/13/2024 | Get Alert |
| GYRE | Gyre Therapeutics | $0.02 | — | $0.01 | — | $29.33M | — | $25.23M | — | 08/13/2024 | Get Alert |
| GYRE | Gyre Therapeutics | $0.03 | — | $0.03 | — | $24.93M | — | $27.17M | — | 05/09/2024 | Get Alert |
| GYRE | Gyre Therapeutics | $0.03 | — | -$1.41 | — | $102.29M | — | $113.45M | — | 03/26/2024 | Get Alert |
Gyre Therapeutics (GYRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Gyre Therapeutics (GYRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Gyre Therapeutics (NASDAQ:GYRE) reporting earnings?
Gyre Therapeutics (GYRE) is scheduled to report earnings on May 20, 2025. The last reported earnings were for reported on March 17, 2025 for Q4.
What were the latest earnings per share (EPS) for Gyre Therapeutics (NASDAQ:GYRE)?
The Actual EPS was $0.00, which hit the estimate of $0.00.
What were Gyre Therapeutics’s (NASDAQ:GYRE) revenues?
The Actual Revenue was $27.9M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
